Medical devices, healthcare technology and the business of care
510(k) clearance · K253436

c-med0 alpha

Cosinuss GmbH · Decision date Apr 30, 2026

FDA DECISIONK253436

What did the FDA decide?

FDA records K253436 as a 510(k) premarket notification, with a decision dated Apr 30, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Apr 30, 2026

FDA source record

Regulatory record facts

Identifier
K253436
Regulatory pathway
510(k) premarket notification
Applicant
Cosinuss GmbH
Product code
MWI
Decision code
SESE
Decision date
Apr 30, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Monitor, Physiological, Patient (Without Arrhythmia Detection Or Alarms).

Applicant
Cosinuss GmbH
Product code
MWI
FDA device class
2

FDA decision timeline

  1. K253436 received

    Application receipt date recorded by FDA.

  2. K253436 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code MWI

Product / regulatory recordCompanyPathwayDecision dateSource
Analog Devices510(k) clearanceOct 16, 2026FDA
Infinium Medical, Inc.510(k) clearanceAug 14, 2026FDA
Masimo Corporation510(k) clearanceAug 12, 2026FDA
Biotracker, LLC510(k) clearanceJun 26, 2026FDA
Midmark Corporation510(k) clearanceJun 12, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Cosinuss GmbH

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Munich

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records